Literature DB >> 9832429

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.

L J Kelly1, P P Vicario, G M Thompson, M R Candelore, T W Doebber, J Ventre, M S Wu, R Meurer, M J Forrest, M W Conner, M A Cascieri, D E Moller.   

Abstract

A role for peroxisome proliferator-activated receptors, PPAR gamma and PPAR alpha, as regulators of energy homeostasis and lipid metabolism, has been suggested. Recently, three distinct uncoupling protein isoforms, UCP-1, UCP-2, and UCP-3, have also been identified and implicated as mediators of thermogenesis. Here, we examined whether in vivo PPAR gamma or PPAR alpha activation regulates the expression of all three UCP isoforms. Rats or lean and db/db mice were treated with PPAR gamma [thiazolidinedione (TZD)] or PPAR alpha (WY-14643) agonists, followed by measurement of messenger RNAs (mRNAs) for UCP-1, UCP-2, and UCP-3 in selected tissues where they are expressed. TZD treatment (AD 5075 at 5 mg/kg x day) of rats (14 days) increased brown adipose tissue (BAT) depot size and induced the expression of each UCP mRNA (3x control levels for UCP-1 and UCP-2, 2.5x control for UCP-3). In contrast, UCP-2 and UCP-3 mRNA levels were not affected in white adipose tissue or skeletal muscle. Chronic (30 days) low-dose (0.3 mg/kg x day) TZD treatment induced UCP-1 mRNA and protein in BAT (2.5x control). In contrast, chronic TZD treatment (30 mg/kg x day) suppressed UCP-1 mRNA (>80%) and protein (50%) expression in BAT. This was associated with further induction of UCP-2 expression (>10-fold) and an increase in the size of lipid vacuoles, a decrease in the number of lipid vacuoles in each adipocyte, and an increase in the size of the adipocytes. TZD treatment of db/db mice (BRL 49653 at 10 mg/kg x day for 10 days) also induced UCP-1 and UCP-3 (but not UCP-2) expression in BAT. PPAR alpha is present in BAT, as well as liver. Treatment of rats or db/db mice with WY-14643 did not affect expression of UCP-1, -2, or -3 in BAT. Hepatic UCP-2 mRNA was increased (4x control level) in db/db and lean mice, although this effect was not observed in rats. Thus, in vivo PPAR gamma activation can induce expression of UCP-1, -2, and -3 in BAT; whereas chronic-intense PPAR gamma activation may cause BAT to assume white adipose tissue-like phenotype with increased UCP-2 levels. PPAR alpha activation in mice is sufficient to induce liver UCP-2 expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832429     DOI: 10.1210/endo.139.12.6384

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  67 in total

Review 1.  Control of energy metabolism by iodothyronines.

Authors:  A Lanni; M Moreno; A Lombardi; P de Lange; F Goglia
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

2.  Apelin Enhances Brown Adipogenesis and Browning of White Adipocytes.

Authors:  Aung Than; Hui Ling He; Si Hui Chua; Dan Xu; Lei Sun; Melvin Khee-Shing Leow; Peng Chen
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

3.  Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Authors:  Efren Riu; Tura Ferre; Alex Mas; Antonio Hidalgo; Sylvie Franckhauser; Fatima Bosch
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

4.  Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver.

Authors:  Chi-Dan Wan; Chun-You Wang; Tao Liu; Rui Cheng; Hong-Bo Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

5.  Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats.

Authors:  Randy L Hunter; Dong-Young Choi; Stuart A Ross; Guoying Bing
Journal:  Neurosci Lett       Date:  2008-01-22       Impact factor: 3.046

6.  Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

Authors:  Weimin He; Yaacov Barak; Andrea Hevener; Peter Olson; Debbie Liao; Jamie Le; Michael Nelson; Estelita Ong; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

7.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  Maryam Rakhshandehroo; Bianca Knoch; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2010-09-26       Impact factor: 4.964

Review 8.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

9.  Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice.

Authors:  D Sanoudou; A Duka; K Drosatos; K C Hayes; V I Zannis
Journal:  Pharmacogenomics J       Date:  2009-12-01       Impact factor: 3.550

10.  The increase in hepatic uncoupling by fenofibrate contributes to a decrease in adipose tissue in obese rats.

Authors:  Mi-Kyoung Park; Hye-Jeong Lee; Sook-Hee Hong; Sun-Seob Choi; Young Hyun Yoo; Kyung Il Lee; Duk Kyu Kim
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.